A drug undergoing clinical trials for sleeping sickness could also treat leishmaniasis, say researchers who have tested it on mice.

A bioprospecting project in Panama is the first to be funded by the Nagoya Protocol Implementation Fund.

Unprecedented collaboration by drug firms, ambitious targets and more funds form part of a new fight against neglected tropical diseases.

A modelling study of a promising malaria vaccine finds low transmission areas would benefit the most from mass vaccination.

The key malaria drug, artemisinin, can now be produced in greater quantities ― from a waste material of the current production process.

A vaccine candidate that exploits how the malaria parasite enters human red blood cells is set to enter safety trials.

US-funded medical trials overseas could follow local ethical procedures if they offer 'equivalent protection', says a report.

A new formulation of benznidazol, at a dose suitable for children, will be produced and distributed at cost for Latin American countries.

Acting fast with the right antivenom following a bite from a dangerous snake could be easier with a new dipstick test, researchers say.

Global funding for R&D on neglected diseases has suffered a blow, with funders pulling out in the wake of the economic crisis.

A new trial has found that tenofovir gel, previously found to be effective, does not prevent HIV infection.

Egyptian scientists are developing a diabetes treatment from bitter gourd, but the jury is out on whether it could replace insulin.

Scientists have identified a single step that the deadly Plasmodium falciparum malaria parasite appears to rely on to invade cells.

Joining forces would save countries money on clinical trials, and speed up drug development for neglected diseases, says a report.

An initiative launched by major patent holders will improve access to neglected disease research, but only 49 countries will freely benefit.

Researchers have created a database of the chemicals in 300 Chinese herbs used in traditional medicine.

A rising burden of non-communicable diseases in Africa requires more investment in science, a conference has heard.

Indian company Aurobindo Pharma will manufacture several antiretroviral medicines licensed to the Medicines Patent Pool.

Results from phase III clinical trials in Africa show a vaccine protects children from malaria, but with a modest efficacy.

A new website aims to improve medical ethics in developing nations by providing information and a forum for discussion.